7月29日，南下资金今日净买入港股127.2亿港元。 其中，净买入小米集团-W 16.59亿、腾讯控股8.32亿、阿里巴巴-W 7.53亿、石药集团6.51亿、信达生物 5.14亿、国泰君安国际4.3亿、中芯国际3.66亿、锦欣生殖1.94亿；净卖出泡泡玛特3.51亿、美团-W 2.87 亿。 | | 沪股通 | | | 深股通 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 深跌幅 | 净头入额(亿) | 成交额 | 名称 | 涨跌幅 | 净买入额(亿) | 成交额 | | 小米製A-W | -2.6% | 9.89 | 53.64 L | 小米菲N-W | -2.6% | 6.70 | 30.04 Z | | 国泰君安国际 | 0.3% | 1.69 | 41.48亿 | 美团-W | -0.6% | -5.09 | 16.85 4 | | 腾讯控股 | -0.1% | 10.60 | 30.04 (Z | M-Dialiba | 0.1% | 5.51 | 16.45 Z | | 阿里巴巴-W | 0.1% | 2.02 ...

每经AI快讯，7月29日，恒生指数下跌0.15%。南向资金今日净买入127.20亿港元。 南向资金成交活跃个股榜单中，净买入个股共8只，金额最多的是小米集团-W（1810.HK，收盘价： 55.3港元），净买入16.592亿港元；净卖出个股共3只，金额最多的是泡泡玛特（9992.HK，收盘价： 261.8港元），净卖出3.513亿港元。 | 南向资金今日成交活跃个股榜单 | | --- | | 代码 | 简称 | 收盘价 (港元) | 涨跌幅 (%) | 净买入金额 (亿港元) | | | --- | --- | --- | --- | --- | --- | | 1810.HK | 小米集团-W | 55.3 | -2.64 | 16.59 | - | | 0700.HK | 腾讯控股 | 555.0 | -0.09 | 8.33 | . | | 9988.HK | 阿里巴巴-W | 120.7 | 0.08 | 7.53 | - | | 1093.HK | 石药集团 | 9.87 | 8.46 | 6.52 | - | | 1801.HK | 信达生物 | 99.95 | 6.44 | 5.14 | | ...

| 港股通(沪)活跃成交股 | | --- | 智通财经APP获悉，7月29日港股市场，北水成交净买入127.2亿港元，其中港股通(沪)成交净买入58.78 亿港元，港股通(深)成交净买入68.42亿港元。 北水净买入最多的个股是小米集团-W(01810)、腾讯(00700)、阿里巴巴-W(09988)。北水净卖出最多的 个股是南方恒生科技(03033)。 | 股票名称 | 买入额 | 卖出额 | 买卖总额 | | --- | --- | --- | --- | | | | | 净流入 | | 小米集团-W | 31.76亿 | 21.87 乙 | 53.64亿 | | HK 01810 | | | +9.89 亿 | | 国泰君安 ... | 21.58 亿 | 19.90亿 | 41.48亿 | | HK 01788 | | | +1.69 乙 | | 腾讯控股 | 20.32 乙 | 9.72 亿 | 30.04亿 | | HK 00700 | | | +10.60 亿 | | 阿里巴巴-W | 12.23 乙 | 10.21 乙 | 22.43亿 | | HK 09988 | | | +2.02亿 | ...

Core Viewpoint - The national childcare subsidy policy will provide an annual subsidy of 3600 yuan per child until the age of three, benefiting over 20 million families each year starting from January 1, 2025 [4][5]. Subsidy Standard - Each child will receive a subsidy of 3600 yuan per year until they turn three years old. For children born before January 1, 2025, who are under three years old, the subsidy will be calculated based on the remaining months [8]. Coverage - The policy applies to all families with children under three years old, regardless of whether they have one, two, or three children, and is uniformly implemented across the country [9]. Application Process - Parents or guardians can apply for the subsidy online through the childcare subsidy information management system or offline, providing necessary documents such as birth certificates and household registration books [10]. Funding Source - The central government will establish a "childcare subsidy fund," providing financial support to eastern, central, and western regions proportionally, with any additional local funding being the responsibility of local governments [11]. Market Impact Analysis - The infant food market is expected to exceed 72 billion yuan, directly benefiting the maternal and infant consumption industry chain [12]. - The childcare industry is projected to reach a scale of 162.1 billion yuan by 2025, with an average annual growth rate of 7.5%, accelerated by the policy [13]. - Demand for children's medical and nutritional health products is anticipated to rise, with the pediatric medication market expected to grow at a rate exceeding 10% annually [14]. Beneficiary Companies - Leading maternal and infant retail companies are expected to benefit directly from increased customer spending and frequency of purchases [15]. - Companies such as Kidswant and Huaiying Room are positioned to gain from the subsidy implementation due to their extensive retail networks and service offerings [16]. - Major players in the infant formula market, like China Feihe and Yili, are likely to see increased demand driven by the subsidy [17][18].

Group 1 - Southbound funds net bought Hong Kong stocks worth 12.72 billion HKD today, with notable purchases in Xiaomi Group-W (1.659 billion), Tencent Holdings (0.832 billion), and Alibaba-W (0.753 billion) [1] - Southbound funds have net bought Tencent for four consecutive days, totaling 2.08902 billion HKD, and Xiaomi for three consecutive days, totaling 2.44603 billion HKD [1] - Other significant net purchases include Sino Biopharmaceutical (0.651 billion), InnoCare Pharma (0.514 billion), and SMIC (0.366 billion) [1] Group 2 - In the Shanghai Stock Connect, Xiaomi Group-W saw a decrease of 2.6% with a net buy of 0.989 billion, while Tencent Holdings increased by 0.1% with a net buy of 1.060 billion [3] - Alibaba-W had a slight increase of 0.1% with a net buy of 0.202 billion, and SMIC rose by 0.5% with a net buy of 0.243 billion [3] - Meituan-W experienced a decline of 0.6% with a net sell of 0.221 billion, while Pop Mart saw a significant increase of 5.9% with a net sell of 0.272 billion [3]

智通财经APP获悉，7月29日港股市场，北水成交净买入127.2亿港元，其中港股通(沪)成交净买入58.78 亿港元，港股通(深)成交净买入68.42亿港元。 | 石药集团 HK 01093 | 5.88亿 | 3.24亿 | 9.11亿 +2.64亿 | | --- | --- | --- | --- | | 信达生物 | 6.77亿 | 1.62亿 | 8.39亿 | | HK 01801 | | | +5.14亿 | | 泡泡玛特 | 3.63亿 | 4.43亿 | 8.06亿 | | HK 09992 | | | -7973.47万 | 港股通(深)活跃成交股 北水净买入最多的个股是小米集团-W(01810)、腾讯(00700)、阿里巴巴-W(09988)。北水净卖出最多的 个股是南方恒生科技(03033)。 | 股票名称 | 买入额 | 卖出额 | 买卖总额 净流入 | | --- | --- | --- | --- | | 小米集团-W HK 01810 | 31.76亿 | 21.87 乙 | 53.64亿 +9.89亿 | | 国泰君安 ... | 21.58 乙 | 19.90亿 | 41. ...

Market Overview - The Hong Kong stock market indices showed a recovery in the afternoon, with the Hang Seng Index and the Hang Seng China Enterprises Index down by 0.15% and 0.34% respectively, while the Hang Seng Tech Index fell by 0.35% after a larger drop of 2% during the day [1][2] - Despite the index adjustments, southbound funds significantly net bought over 10 billion HKD in Hong Kong stocks [1] Sector Performance - Large tech stocks saw a narrowing of losses in the afternoon, with Alibaba slightly turning positive, while Tencent, JD.com, Meituan, and Kuaishou experienced declines within 1%. Xiaomi continued to decline by 2.6% [2] - Biopharmaceutical stocks performed strongly, particularly in the innovative drug sector, with WuXi AppTec rising over 11%, and both CSPC Pharmaceutical and Luye Pharma increasing by over 8% [2] - The "anti-involution" sectors, including steel and photovoltaic stocks, showed a notable recovery, while oil, gambling, and semiconductor stocks mostly rose [2] - The three-child policy subsidy of 3600 yuan led to a mixed performance in related stocks, with some experiencing declines [2][6] Banking Sector - The banking sector faced declines, with several banks such as Chongqing Rural Commercial Bank and China Everbright Bank dropping over 3% [4][5] - Major banks like Industrial and Commercial Bank of China, China Construction Bank, and Agricultural Bank of China also saw declines [4] Biopharmaceutical Sector - WuXi AppTec reported a strong performance with a revenue of 20.8 billion yuan for the first half of 2025, a year-on-year increase of 20.64%, and a net profit surge of 101.92% [8] - The company expects continued double-digit growth in operating revenue, adjusting its growth forecast from 10-15% to 13-17% [8] Automotive Sector - Automotive dealership stocks rose against the trend, with Guanzhong Holdings increasing over 9% and Zhongsheng Holdings up over 6% [9][10] - UBS reported that the rebound in stock prices for Zhongsheng and Yongda Automotive is attributed to expectations of improved profit margins from new car sales due to government policies [10] Steel Sector - Steel stocks experienced gains, with Maanshan Iron & Steel rising over 8% and several other companies like Ansteel and Asia Pacific Resources also seeing increases [11][12] Apple-Related Stocks - Apple-related stocks were active, with AAC Technologies rising over 3% and other companies like GoerTek and BYD Electronics also showing gains [13] Future Outlook - Haitong Securities expressed optimism about the Hong Kong stock market, particularly in the technology sector, suggesting a focus on sectors with improving conditions and low valuations [15]

Group 1 - The national childcare subsidy policy will be implemented starting January 1, 2025, providing annual subsidies of 3,600 yuan per child for infants under three years old [1] - The policy marks a shift from previous regional subsidies focused on families with two or more children to a nationwide coverage, which is expected to boost consumer sentiment in the maternal and infant market [2] - The introduction of the subsidy is anticipated to support the assisted reproductive market, providing assistance to families wishing to have children [2] Group 2 - The macro policy benefits indicate a clear growth direction for the industry, with subsidies and incentives elevating the assisted reproductive sector to a core component of national population strategy [2] - The integration of assisted reproduction into health insurance is expected to lower the cost barrier for treatments, thereby increasing demand for related medical services and products [2] - Companies like Beikang Medical are positioned to benefit from these policies, with their strategic focus aligning with the growing market demand [2][5] Group 3 - Beikang Medical is leveraging its technological and product advantages to capture market opportunities in underdeveloped segments, such as genetic testing and male reproductive health products [2][5] - The company is expected to lead the domestic market in assisted reproduction, benefiting from both policy support and its established market position [5] - Beikang Medical's valuation may increase as the assisted reproductive industry experiences rapid growth, supported by favorable policies [5] Group 4 - As of July 28, 2025, Beikang Medical's PS (TTM) is 2.447, indicating potential undervaluation compared to its technological barriers and industry leadership [6] - The company is projected to achieve significant revenue growth, with forecasts suggesting revenues could reach 400 million yuan by 2026, leading to a market valuation between 1.6 billion and 2.4 billion yuan [6] - The new national fertility policy, along with local support measures, presents a historic opportunity for the assisted reproductive industry, with Beikang Medical positioned to capitalize on this growth [6]

Group 1: Baby and Childcare Sector - The baby and childcare concept stocks mostly opened higher, with notable increases in shares of companies such as Jinxin Reproductive Medicine (1951.HK) up 8.93%, H&H International Holdings (1112.HK) up 7.33%, and China Feihe (6186.HK) up 5.12% following the announcement of a new childcare subsidy policy [1] - The new policy, effective from January 1, 2025, provides an annual subsidy of 3,600 yuan for each child until they reach three years old, which is expected to boost the sector [1] Group 2: Pharmaceutical Sector - WuXi AppTec (2359.HK) opened over 4% higher after reporting a revenue of 20.799 billion yuan for the six months ending June 30, 2025, a year-on-year increase of 20.6%, with a net profit of 8.287 billion yuan, up 95.5% [1] - Fosun Pharma (2196.HK) saw a 1.37% increase after signing a licensing agreement for AR1001, aimed at treating Alzheimer's disease and other neurological disorders [2] - Deqi Pharmaceutical (6996.HK) rose 4.70% after receiving approval for a new indication of its drug, Xivio, for treating multiple myeloma [2] - Kangzheng Pharmaceutical (0867.HK) increased over 2% after announcing the acceptance of its new drug application for ZUNVEYL, aimed at treating Alzheimer's symptoms [4] - BeiGene (6160.HK) rose over 3% following a positive recommendation from the European Medicines Agency for its drug, Tislelizumab, for non-small cell lung cancer [4] Group 3: Automotive Sector - Hong Kong automotive dealer stocks rose, with Zhongsheng Holdings (0881.HK) up nearly 6% and Yongda Automotive (3669.HK) up over 4%, driven by expectations of improved profit margins from new car sales due to government policies [2] - UBS reported that Zhongsheng and Yongda's stock prices rebounded approximately 20% and 5% respectively, as the market anticipates industry consolidation and improved profitability [2] Group 4: Beverage Sector - Hong Kong Brewery (0236.HK) surged 26% after reporting a revenue of approximately 390 million HKD for the first half of 2025, a year-on-year increase of 3.22%, with a net profit of 49.644 million HKD, up 31.97% [3] Group 5: Securities Sector - Chinese brokerage stocks collectively declined, with Shenwan Hongyuan (6806.HK) down nearly 5%, amid tightening regulatory scrutiny in the securities industry, which has seen over 30 fines issued recently [3]

Group 1 - The implementation of the childcare subsidy policy has led to a significant rise in the mother and baby industry, particularly in the dairy sector, with companies like Sunshine Dairy reaching the daily limit increase [1][11] - The national childcare subsidy is set at 3600 yuan per child per year, which, while not fully covering the average annual cost of raising a child (approximately 25,000 yuan), sends a strong policy signal and is expected to expand the maternal and infant consumption market by 5%-8% [7][10] - Local governments have already initiated their own subsidy programs, with notable examples including Hohhot and Hangzhou, which have implemented substantial financial support for families based on the number of children [10][12] Group 2 - The dairy industry is anticipated to be one of the first beneficiaries of the subsidy, particularly in the consumption of milk powder, which could enhance the sector's overall performance [11][13] - Analysts believe that the subsidy will not only reduce the cost of childbirth for families but also boost birth rates, especially benefiting the lower-tier markets and various maternal and infant consumer goods [14] - Companies such as Kidswant, Saint Bella, and Aiyingshi are expected to benefit from the ongoing changes in the childcare subsidy landscape, with potential growth in early education and training institutions as well [14]